First Light Asset Management, LLC

Add to watchlist

$859 Million is the total value of First Light Asset Management, LLC's 71 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

All

		Value		Shares		↓ Weighting
ANTM	ELEVANCE HEALTH INC	$600,000	-1.8%	1,244	0.0%	0.07%	+29.6%
UTHR	UNITED THERAPEUTICS CORP DEL	$581,000	+31.4%	2,466	0.0%	0.07%	+74.4%
ABBV	ABBVIE	$573,000	-5.4%	3,740	0.0%	0.07%	+26.4%
BMY	BRISTOL-MYERS SQUIBB CO	$559,000	+5.5%	7,256	0.0%	0.06%	+38.3%
GSK	GLAXOSMITHKLINE PLC	$547,000	-0.2%	12,574	0.0%	0.06%	+33.3%
CI	CIGNA CORPORATION	$512,000	+9.9%	1,943	0.0%	0.06%	+46.3%
CVS	CVS HEALTH CORPORATION	$511,000	-8.6%	5,519	0.0%	0.06%	+20.4%
WAT	WATERS CORPORATION	$508,000	+6.5%	1,536	0.0%	0.06%	+40.5%
HUM	HUMANA INC	$500,000	+7.5%	1,068	0.0%	0.06%	+41.5%
BDX	BECTON DICKINSON AND CO	$465,000	-7.4%	1,888	0.0%	0.05%	+22.7%
AVTR	AVANTOR INC	$454,000	-8.1%	14,596	0.0%	0.05%	+20.5%
NVST	ENVISTA HOLDINGS CORP	$455,000	-20.7%	11,793	0.0%	0.05%	+3.9%
MCK	MCKESSON CORP	$439,000	+6.6%	1,346	0.0%	0.05%	+41.7%
GILD	GILEAD SCIENCES INC	$414,000	+3.8%	6,705	0.0%	0.05%	+37.1%
SYNH	SYNEOS HEALTH INC CLASS A	$411,000	-11.4%	5,736	0.0%	0.05%	+17.1%
ITGR	INTEGER HOLDINGS CORPORATION	$413,000	-12.3%	5,846	0.0%	0.05%	+14.3%
HOLX	HOLOGIC INC	$405,000	-9.8%	5,845	0.0%	0.05%	+17.5%
PRGO	PERRIGO COMPANY	$399,000	+5.8%	9,823	0.0%	0.05%	+39.4%
NUVA	NUVASIVE INC	$386,000	-13.3%	7,850	0.0%	0.04%	+15.4%
JNJ	JOHNSON & JOHNSON	$384,000	+0.3%	2,161	0.0%	0.04%	+32.4%
BAX	BAXTER INTERNATIONAL INC	$381,000	-17.2%	5,929	0.0%	0.04%	+7.3%
TAK	TAKEDA PHARMACEUTICAL CO	$360,000	-1.9%	25,630	0.0%	0.04%	+31.2%
SNY	SANOFI-SYNTHELABO	$333,000	-2.3%	6,650	0.0%	0.04%	+30.0%
ICUI	ICU MEDICAL INC	$335,000	-26.2%	2,039	0.0%	0.04%	-2.5%
UHS	UNIVERSAL HEALTH SERVICES INC CLASS B	$206,000	-30.6%	2,050	0.0%	0.02%	-7.7%

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2022-08-12

Signatures

The EDGAR filing(s) were signed by:

Kurt T. Peterson — Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ATRICURE INC	40	Q3 2023	9.7%
NEOGENOMICS INC	40	Q3 2023	10.6%
SANOFI-SYNTHELABO	40	Q3 2023	1.9%
JOHNSON & JOHNSON	40	Q3 2023	0.3%
PFIZER INC	39	Q2 2023	0.9%
BIOMARIN PHARMACEUTICAL INC	36	Q3 2023	1.6%
OMNICELL INC	33	Q3 2023	7.7%
QUIDEL CORP	33	Q4 2021	3.7%
NOVARTIS AG-SPONSORED ADR	33	Q3 2023	0.4%
MODEL N INC	30	Q3 2023	9.0%

View First Light Asset Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

First Light Asset Management, LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
REATA PHARMACEUTICALS INC	May 15, 2023	1,290,193	3.9%
Axogen, Inc.	February 03, 2023	1,942,270	4.6%
MODEL N, INC.	February 03, 2023	1,845,134	4.9%
MEI Pharma, Inc.^{Sold out}	May 31, 2022	0	0.0%
PROTHENA CORP PUBLIC LTD CO	March 01, 2022	1,805,038	3.9%
Intersect ENT, Inc.	February 14, 2022	1,375,210	4.1%
SeaSpine Holdings Corp	February 14, 2022	6,847,707	18.8%
Oxford Immunotec Global PLC^{Sold out}	February 10, 2021	0	0.0%
ENDOLOGIX INC /DE/	February 14, 2020	816,236	4.6%
Nuvectra Corp^{Sold out}	February 14, 2020	0	0.0%

View First Light Asset Management, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13D/A	2024-04-09
4	2024-04-08
13F-HR	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G	2024-02-14
SC 13G	2024-02-14
SC 13G	2024-02-14
SC 13G	2024-02-14
SC 13G	2024-02-14

View First Light Asset Management, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export First Light Asset Management, LLC's holdings